Talking Points

Lepodisiran Phase I Trial


Episode Artwork
1.0x
0% played 00:00 00:00
Feb 07 2024 5 mins  
Other Episodes
Steven Nissen and C. Michael Gibson discuss the efficacy and safety of lepodisiran, an extended duration short-interfering RNA meant to reduce lipoprotein (a).
Download episode Share
Copy URL



Subscribe on Podcast Addict